Banks can accelerate innovation by defining problems clearly and using pre-validation, standardisation, and collaboration to move ideas into adoption faster.
Banks do not lack ideas. The real challenge is turning those ideas into production-ready solutions.
Central bank governors' live card payment, barq's $329.5m Series A and a new SME financing fund made Money20/20 Middle East's second day about capital.
Central bank governors' live card payment, barq's $329.5m Series A and a new SME financing fund made Money20/20 Middle East's second day about capital.
As agent payment protocols solve identity and consent, a critical verification gap at the moment of payment threatens the auditability of autonomous commerce.
As agent payment protocols solve identity and consent, a critical verification gap at the moment of payment threatens the auditability of autonomous commerce.
NymCard raises $33M in Series B funding led by QED Investors, accelerating its fintech expansion across MENA with cutting-edge payment solutions for banks, fintechs, and enterprises.
LEAP 2025 showcased Saudi Arabia’s commitment to financial technology and digital transformation, playing host to experts and organisations sharing their latest accomplishments and in
e& UAE partners with Kindred.co to introduce “Save & Grow,” a first-of-its-kind initiative enabling users to save on purchases while supporting environmental sustainability throug
Brazil’s Supreme Federal Court has upheld a law mandating biodegradable and oxo-biodegradable plastic bags, marking a major victory for sustainability.
LEAP 2025 in Riyadh not only revealed a $14.9billion investment in artificial intelligence but also served as a platform for major technology showcases.
China's state nuclear corporation proposed a new international cooperation platform to move fusion energy from lab research toward engineering application.
The OTCQB-listed waste-to-fuel developer is commissioning its first commercial RDF-to-methanol module in Portugal, backed by non-dilutive STEP programme funding.
The EIB-Angelini Ventures co-investment partnership has backed five European life sciences companies in under a year, with €100m expected deployed by early 2027.